Gary Cutter
Researcher Next ID · RN-033244
Researcher · Medicine
Rutgers, The State University of New Jersey
New Brunswick, Australia
- Works count
- 1,129
- Citation count
- 59,166
- H-index
- 121
- i10-index
- 615
Research interests
Publications
Temporal dynamics of the multi-omic response to endurance exercise training
Nature · 2024 · https://doi.org/10.1038/s41586-023-06877-w
Treatment for Mild Chronic Hypertension during Pregnancy
New England Journal of Medicine · 2022 · 10.1056/nejmoa2201295
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis
New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2201904
Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping With Death or Severe Intraventricular Hemorrhage Among Preterm Infants
JAMA · 2019 · https://doi.org/10.1001/jama.2019.16004
The prevalence of MS in the United States
Neurology · 2019 · https://doi.org/10.1212/wnl.0000000000007035
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)31817-3
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
The Lancet Neurology · 2019 · https://doi.org/10.1016/s1474-4422(18)30392-2
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
The Lancet Neurology · 2019 · https://doi.org/10.1016/s1474-4422(18)30392-2
Cell-based therapeutic strategies for multiple sclerosis
Brain · 2017 · https://doi.org/10.1093/brain/awx154
Randomized Trial of Thymectomy in Myasthenia Gravis
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1602489
Prevalence odds ratio versus prevalence ratio: choice comes with consequences
Statistics in Medicine · 2016 · 10.1002/sim.7059
Long‐term evolution of multiple sclerosis disability in the treatment era
Annals of Neurology · 2016 · 10.1002/ana.24747
Extended interval dosing of natalizumab in multiple sclerosis
Journal of Neurology Neurosurgery & Psychiatry · 2016 · https://doi.org/10.1136/jnnp-2015-312940
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Multiple Sclerosis Journal · 2015 · 10.1177/1352458514564491
Defining reliable disability outcomes in multiple sclerosis
Brain · 2015 · https://doi.org/10.1093/brain/awv258
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Multiple Sclerosis Journal · 2015 · 10.1177/1352458514564487
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(13)62337-5
Defining the clinical course of multiple sclerosis
Neurology · 2014 · https://doi.org/10.1212/wnl.0000000000000560
Natural History of Multiple Sclerosis Symptoms
International Journal of MS Care · 2013 · 10.7224/1537-2073.2012-053
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis
Annals of Neurology · 2010 · 10.1002/ana.22005
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
Neurology · 2010 · 10.1212/wnl.0b013e3181d6b125
Risk of Serious Injury for Young Baseball Pitchers
The American Journal of Sports Medicine · 2010 · 10.1177/0363546510384224
Influence of Computer-Aided Detection on Performance of Screening Mammography
New England Journal of Medicine · 2007 · 10.1056/nejmoa066099
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
Neurology · 2007 · 10.1212/01.wnl.0000295995.46586.ae
Effect of relapses on development of residual deficit in multiple sclerosis
Neurology · 2003 · 10.1212/01.wnl.0000096175.39831.21
Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography
Annals of Internal Medicine · 2003 · https://doi.org/10.7326/0003-4819-138-3-200302040-00008
Eight-year follow-up study of brain atrophy in patients with MS
Neurology · 2002 · 10.1212/01.wnl.0000036271.49066.06
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
Neurology · 2002 · 10.1212/wnl.59.5.679
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
Brain · 1999 · https://doi.org/10.1093/brain/122.5.871
The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment
Multiple Sclerosis Journal · 1999 · 10.1177/135245859900500409
Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn
The Journal of Pediatrics · 1997 · 10.1016/s0022-3476(97)70124-0
Recommendations from the national multiple sclerosis society clinical outcomes assessment task force
Annals of Neurology · 1997 · 10.1002/ana.410420318
Initial Acquisition of Mutans Streptococci by Infants: Evidence for a Discrete Window of Infectivity
Journal of Dental Research · 1993 · 10.1177/00220345930720010501
Cardia: study design, recruitment, and some characteristics of the examined subjects
Journal of Clinical Epidemiology · 1988 · https://doi.org/10.1016/0895-4356(88)90080-7
Current projects
No projects listed.